Approval · Notice of Compliance 2576 · 2001
SEROSTIM: Notice of Compliance 2576
Issued July 27, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2576
- Date
- July 27, 2001
- Company
- Serono Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Human growth hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SEROSTIM | 02244373 | — |
Medicinal ingredients
- SOMATROPIN 4 MG per VIAL